Friday, November 16, 2007
Print Current Day:
|
|
SESSION XIX SCHEDULE | |
Friday
SESSION XIX:
FOCUS ON NEW OR IMPROVED TECHNOLOGY AND RESULTS THEREFROM (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D. / Daniel G. Clair, M.D.
|
|
x | |
6:40 AM - 6:47 AM | How To Perform Cryotherapy, Atherectomy And Laser Treatment For Lower Extremity Occlusive Disease: How Do We Know They Are Worthwhile And Worth The Cost? |
Presenters: Kim J. Hodgson, M.D. | |
6:48 AM - 6:55 AM | Results With Cryoplasty To Treat Below-Knee Lesions: Is It Better Than Other Techniques? |
Presenters: Thomas O. McNamara, M.D. | |
6:56 AM - 7:03 AM | What’s Cool About Cryoplasty: 2 ½ -Year Results Based On An Analysis Of Treated Lesions |
Presenters: Russell H. Samson, M.D., F.A.C.S., R.V.T. | |
7:04 AM - 7:11 AM | What Is The Evidence For The Efficacy Of Cryoplasty? |
Presenters: David O. Kessel, M.D. | |
7:12 AM - 7:19 AM | Clopidogrel Resistance in CAS: How to Diagnose It and Manage It |
Presenters: Zvonimir Krajcer, M.D., F.A.C.C. | |
7:20 AM - 7:28 AM | Panel Discussion |
7:28 AM - 7:35 AM | General Remarks About The Meeting |
Presenters: Frank J. Veith, M.D. | |
END OF SESSION XIX | |
SESSION XX SCHEDULE | |
Friday
SESSION XX:
PROGRESS IN THE TREATMENT OF THORACIC AND THORACOABDOMINAL AORTIC ANEURYSMS (7-MINUTE TALKS)
Moderators:Krassi Ivancev, M.D., Ph.D. / Frank J. Veith, M.D.
|
|
x | |
7:35 AM - 7:42 AM | Tips And Tricks For Performing Aortic Arch Debranching Safely |
Presenters: Blair A. Keagy, M.D. | |
7:43 AM - 7:50 AM | Complications Of Arch And Visceral Debranching: It’s Not Easy And Has Morbidity And Mortality: When Is It Better To Use Endovascular Graft Revascularization Of Branches With Open Repair (The Viabahn Open Repair Technique)? |
Presenters: Mario Lachat, M.D. / Dieter O. Mayer, M.D. | |
7:51 AM - 7:58 AM | Laparoscopic Debranching To Facilitate EVAR: Is It Better Than Open Debranching And Branched Endografts? |
Presenters: Ralf R. Kolvenbach, M.D. | |
7:59 AM - 8:06 AM | Can The Celiac Axis Origin Be Covered Safely By Thoracic Endografts: Indications And Precautions |
Presenters: William D. Jordan, Jr., M.D. | |
8:07 AM - 8:14 AM | EVAR And TEVAR For Mycotic Aneurysms And Aortovisceral Fistulas: How To Make Them Work |
Presenters: George H. Meier III, M.D. | |
8:15 AM - 8:22 AM | Computer Automated Planning For Branched And Fenestrated Endografts |
Presenters: Roy K. Greenberg, M.D. | |
8:23 AM - 8:30 AM | Are There Anatomical Limitations To Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms? |
Presenters: Eric L.G. Verhoeven, M.D., Ph.D. | |
8:31 AM - 8:38 AM | What’s New In In Situ Fenestration With Thoracic Stent Grafts? |
Presenters: Ramesh K. Tripathi, M.D., F.R.C.S., F.R.A.C.S. | |
8:39 AM - 8:46 AM | What Is The Explanation For Performance Differences With The Gore TAG Endograft In The Pivotal Trial And In Subsequent Usage? |
Presenters: Jon S. Matsumura, M.D. | |
8:47 AM - 8:54 AM | Use Of CardioMems Pressure Sensor With TEVAR: Can It Improve Outcomes? |
Presenters: Karthikeshwar Kasirajan, M.D. | |
8:55 AM - 9:05 AM | Panel Discussion |
END OF SESSION XX | |
SESSION XXI SCHEDULE | |
Friday
SESSION XXI:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ARTERIAL DISEASE (5-MINUTE FAST PACED TALKS)
Moderators:Enrico Ascher, M.D. / Peter F. Lawrence, M.D.
|
|
x | |
9:05 AM - 9:10 AM | Supervised Exercise For Intermittent Claudication: A Forgotten Treatment Method |
Presenters: Alun H. Davies, M.A., D.M., F.R.C.S. | |
9:11 AM - 9:16 AM | Do SFA Stents And Other Treatment Method Trials Require A “Best Medical Treatment Control Cohort”? |
Presenters: Samuel Eric Wilson, M.D. | |
9:17 AM - 9:22 AM | What Is The Level I Evidence Showing That Stenting Is Better Than Plain Old Balloon Angioplasty For Occlusive Lesions In The SFA? |
Presenters: Johannes Lammer, M.D. | |
9:23 AM - 9:28 AM | Debunking The Myth That Failed SFA Interventions Or Bypasses Convert A Patient With Claudication To Critical Ischemia |
Presenters: Christopher L. Wixon, M.D. | |
9:29 AM - 9:34 AM | Axillopopliteal Bypass: Does It Have A Role In Today’s Vascular Treatment: Indications, Results And Techniques |
Presenters: Frans L. Moll, M.D., Ph.D. | |
9:35 AM - 9:40 AM | Debate: Worldwide Clinical Performance Of Gore Propaten Heparin Bonded PTFE Grafts To Below-Knee Arteries: Will They Be Better Than Saphenous Vein Or Distaflo™ Grafts? |
Presenters: Richard F. Neville, M.D. | |
9:41 AM - 9:46 AM | Debate: Distaflo™ Grafts: Are They Better Than Vein Or Propaten Grafts? |
Presenters: Peter L. Harris, M.D., F.R.C.S. | |
9:47 AM - 9:52 AM | Long-Term Results Of Subintimal Recanalization Below The Inguinal Ligament |
Presenters: Krassi Ivancev, M.D., Ph.D. | |
9:53 AM - 10:00 AM | Panel Discussion |
Moderator(s): Robert B. Rutherford, M.D. / R. Clement Darling III, M.D. | |
10:00 AM - 10:05 AM | Comparison Of Surgical And Endovascular Revision Of Failing Infrainguinal Bypass Grafts: When Is Endovascular Equivalent And When Inferior? |
Presenters: Michael S. Conte, M.D. | |
10:06 AM - 10:11 AM | Effect Of Lesion Characteristics, Diabetes And Runoff On Outcome Of Lower Extremity Angioplasty And Stenting: Is Bypass Ever A Preferred Option? |
Presenters: Peter L. Faries, M.D., F.A.C.S. | |
10:12 AM - 10:17 AM | Debate: Duplex Surveillance Is Worthwhile After Endovasclar Procedures On Infrainguinal Arteries: Is It Better Than Warfarin? |
Presenters: Dennis F. Bandyk, M.D. | |
10:18 AM - 10:23 AM | Debate: Duplex Surveillance Is Not Worthwhile After Endovascular Procedures On Infrainguinal Arteries |
Presenters: Joseph L. Mills, M.D. | |
10:24 AM - 10:29 AM | A New Dorsolateral Approach To The Perineal Artery For Limb Salvage Bypasses: Techniques And Advantages |
Presenters: E. Sebastian Debus, M.D. | |
10:30 AM - 10:35 AM | Angiogenic Gene Therapy In Chronic Limb Ischemia: Is There Any Hope That It Will Work? |
Presenters: Richard J. Powell, M.D. | |
10:36 AM - 10:41 AM | Popliteal Volume Flow Measurements With Duplex Is A Reliable Predictor Of Early And Midterm Patency After PTA And Subintimal PTA: It Should Be A Guide For Stent Placement |
Presenters: Anil P. Hingorani, M.D. | |
10:42 AM - 10:47 AM | What Factors Make Popliteal Aneurysms Appropriate For Endograft Repair And Which Ones Mandate Open Repair? |
Presenters: Martin R. Back, M.D. | |
10:48 AM - 10:56 AM | Panel Discussion |
END OF SESSION XXI | |
SESSION XXII SCHEDULE | |
Friday
SESSION XXII:
ADVANCES IN MEDICAL TREATMENTS AND TREATMENT OF MEDICAL PROBLEMS IN VASCULAR PATIENTS (7-MINUTE TALKS)
|
|
x | |
10:56 AM - 11:03 AM | What Vascular Surgeons Need To Know About Best Medical Treatment In 2007? |
Presenters: Russell H. Samson, M.D., F.A.C.S., R.V.T. | |
11:04 AM - 11:11 AM | What Is Optimal Antiplatelet Management In 2007? |
Presenters: Anthony J. Comerota, M.D., FACS, FACC | |
11:12 AM - 11:19 AM | So You Think Aspirin Was Forever: A New Look At Antiplatelet And Antiinflammatory Activity In Vascular Disease Patients |
Presenters: A. Ross Naylor, M.D., F.R.C.S. | |
11:20 AM - 11:27 AM | Update On The Rheos System For Treating Drug Resistant Hypertension With An Implantable Carotid Sinus Stimulator: Will It Be Important To Vascular Surgeons? |
Presenters: Jürg Schmidli, M.D. | |
11:28 AM - 11:35 AM | Where Have All The Atherosclerotic Plaques Gone And What Effect Will It Have On Vascular Surgeons? |
Presenters: Allan D. Callow, M.D., Ph.D. | |
11:36 AM - 11:43 AM | New Strategies For Preventing Restenoses After Non-Cardiac Interventions: Drug-Eluting Stents And Balloons, Systemic Drugs And Nano Particles |
Presenters: Lindsay Machan, M.D. | |
11:44 AM - 11:51 AM | Will There Ever Be Medical Treatment To Prevent AAA Growth |
Presenters: Robert W. Thompson, M.D. | |
11:52 AM - 11:58 AM | Aggressive Management Of Massive PE By Catheter Manipulation Without Thrombolytics, Pulmonary Embolectomy Or Clot Extraction |
Presenters: Jacob Cynamon, M.D. | |
12:05 PM - 1:00 PM | Lunch Break |
11:59 PM - 12:05 PM | Panel Discussion |
END OF SESSION XXII | |
SESSION XXIII SCHEDULE | |
Friday
SESSION XXIII:
MORE ABOUT ANEURYSMS AND THEIR TREATMENT (6-MINUTE TALKS)
Moderators:G. Melville Williams, M.D. / Gregg S. Landis, M.D.
|
|
x | |
1:00 PM - 1:06 PM | Direct Sheath Placement Into The Aorta Or Common Iliac Artery To Facilitate Access For TEVAR Or EVAR: When Is It Better Than A Conduit? |
Presenters: Jeffrey P. Carpenter, M.D. | |
1:07 PM - 1:13 PM | Debate: Small AAAs Do Not Become Less Suitable For EVAR If They Are Observed For Long Periods: We Don’t Need A Small AAA Trial |
Presenters: Carlos H. Timaran, M.D. | |
1:14 PM - 1:20 PM | Debate: Small AAAs Do Become Less Suitable For EVAR If They Are Observed: We Do Need A Small AAA Trial: When Will The PIVOTAL Trial Results Be Known? |
Presenters: Daniel G. Clair, M.D. / Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C. | |
1:21 PM - 1:27 PM | With Small AAAs (<5.0 cm), What Are The Predictive Factors For Major Future Growth? |
Presenters: Frans L. Moll, M.D., Ph.D. | |
1:28 PM - 1:34 PM | The EUROSTAR Registry: What Has It Accomplished In Its 10-Year Lifespan? |
Presenters: Peter L. Harris, M.D., F.R.C.S. | |
1:35 PM - 1:41 PM | Comparative Results Of The Zenith And Talent Grafts In The EVAR Trials: Was There A Performance Difference? |
Presenters: Roger M. Greenhalgh, M.D. | |
1:42 PM - 1:48 PM | Which Is The Best Endograft For AAAs: When Is One Device Better? |
Presenters: Clifford J. Buckley, M.D. | |
1:49 PM - 1:55 PM | Comparison Of Device Related Complications With Different Grafts In The EUROSTAR Registry |
Presenters: Jacob Buth, M.D. | |
1:56 PM - 2:02 PM | The End Of Endotension After EVAR: Visualizing Microendoleaks With The New Blood Pool Agent VASOVIST (99): Are These Microendoleaks The Whole Story? |
Presenters: Hence J.M. Verhagen, M.D., Ph.D. | |
2:02 PM - 2:10 PM | Panel Discussion |
END OF SESSION XXIII | |
SESSION XXIV SCHEDULE | |
Friday
SESSION XXIV:
PROGRESS IN VASCULAR IMAGING (7-MINUTE TALKS)
Moderators:Mark A. Adelman, M.D. / Frans L. Moll, M.D., Ph.D.
|
|
x | |
2:10 PM - 2:17 PM | Debate: With Asymptomatic Patients Who Have Arteriosclerotic Risk Factors, The Emphasis Should Be Placed On Carotid Screening Not Medical Treatment |
Presenters: Glenn Jacobowitz, M.D. | |
2:18 PM - 2:25 PM | Debate: With Asymptomatic Patients Who Have Arteriosclerotic Risk Factors, The Emphasis Should Be Placed On Good Medical Treatment (Statins, Beta Blockers, Etc.) Not On Carotid Screening |
Presenters: Geoffrey L. Gilling-Smith, M.S., F.R.C.S. | |
2:26 PM - 2:33 PM | 3D CTA Imaging Of Carotid Lesions Casts A New Light On Degree Of Stenosis |
Presenters: Thomas S. Maldonado, M.D. | |
2:34 PM - 2:41 PM | MRA vs. CTA: Which Is Best For Vascular Imaging In What Locations: Can Gadolinium Be Toxic In Some Settings And What Is Nephrogenic Systemic Fibrosis? |
Presenters: Geoffrey D. Rubin, M.D. | |
2:42 PM - 2:49 PM | New Techniques In Cross-Sectional Imaging: Why Vascular Surgeons Must Master 3D Workstation Skills: What Can Coronary CTA With 64 Slice Scanners Do And Not Do? |
Presenters: Geoffrey D. Rubin, M.D. | |
2:50 PM - 2:57 PM | Importance Of Dynamic Imaging Modalities With CT And MR On Aneurysmal Disease And Its Treatment With EVAR |
Presenters: Hence J.M. Verhagen, M.D., Ph.D. | |
2:58 PM - 3:05 PM | Improvements In IVUS: Why Every Interventionist Must Have It And Use It |
Presenters: Rodney A. White, M.D. | |
3:06 PM - 3:15 PM | Panel Discussion |
END OF SESSION XXIV | |
SESSION XXV SCHEDULE | |
Friday
SESSION XXV:
NEW DEVELOPMENTS IN DIALYSIS ACCESS AND VASCULAR DISEASE AND ITS TREATMENT (7-MINUTE TALKS)
Moderators:Thomas M. Vesely, M.D. / Keith D. Calligaro, M.D.
|
|
x | |
3:15 PM - 3:22 PM | Does DOQI Have It Right? |
Presenters: Marc H. Glickman, M.D. | |
3:23 PM - 3:30 PM | Duplex Diagnosis And Treatment Of Failing AV Access Fistulas And Grafts: A Better More Financially Effective Way |
Presenters: Enrico Ascher, M.D. | |
3:31 PM - 3:38 PM | Update On The Importance Of The VAC Device To Vascular Surgeons |
Presenters: Bauer E. Sumpio, M.D., Ph.D. | |
3:39 PM - 3:46 PM | Intima To Media Thickness As A Marker Of Arteriosclerotic Risk |
Presenters: Richard Hayes, M.D., FACC | |
3:47 PM - 3:52 PM | Panel Discussion |
END OF SESSION XXV | |
SESSION XXVI SCHEDULE | |
Friday
SESSION XXVI:
PROGRESS IN THE TREATMENT OF VENOUS DISEASE (6-MINUTE TALKS)
Moderators:J. Leonel Villavicencio, M.D. / John J. Bergan, M.D.
|
|
x | |
3:52 PM - 3:58 PM | How Long After An Episode Of DVT Should Anticoagulation Be Continued? |
Presenters: Anthony J. Comerota, M.D., FACS, FACC | |
3:59 PM - 4:05 PM | Does Endovascular Ablation For Varicose Veins Cut The Mustard: Results Of A Prospective Randomized Trial From New Zealand |
Presenters: Ramesh K. Tripathi, M.D., F.R.C.S., F.R.A.C.S. | |
4:06 PM - 4:12 PM | Minimal Doses Of Thrombolytic Agent For Treating DVT And Preventing Chronic Venous Insufficiency: Does Intraprocedural Ultrasound Help? |
Presenters: Cynthia K. Shortell, M.D. | |
4:13 PM - 4:19 PM | Results Of Endovenous Treatment In 1,500 Patients With Ileocaval Venous Obstruction: What Vascular Surgeons Need To Know |
Presenters: Seshadri Raju, M.D. | |
4:20 PM - 4:26 PM | Determination Of Resolution Of Upper Extremity Venous Thrombosis: Should Invasive Treatment Be Selective? |
Presenters: Gregory L. Moneta, M.D. | |
4:27 PM - 4:33 PM | Is First Rib Resection Worthwhile For Chronically Occluded Subclavian Veins? |
Presenters: Julie Ann Freischlag, M.D. | |
4:34 PM - 4:40 PM | Long-Term Results With Aggressive And Conservative Treatment For Effort Thrombosis Of The Axillary-Subclavian Veins: Is Aggressive Treatment Really Indicated And What Should It Be? |
Presenters: Karl A. Illig, M.D. | |
4:41 PM - 4:47 PM | Comprehensive Surgical Treatment For Subclavian Vein Effort Thrombosis: Who, What, When, Where And Why? |
Presenters: Robert W. Thompson, M.D. | |
4:48 PM - 4:54 PM | New Techniques And Methods For Treating Ileofemoral DVT |
Presenters: Michael B. Silva, Jr., M.D. | |
4:55 PM - 5:01 PM | Pharmaco-Mechanical Treatment Of DVT: Emerging Device And Clinical Data Using Isolated Thrombolysis |
Presenters: Anthony J. Comerota, M.D., FACS, FACC | |
5:02 PM - 5:10 PM | Panel Discussion |
Moderator(s): Bo G. Eklof, M.D., Ph.D. / Michael C. Dalsing, M.D. | |
5:10 PM - 5:16 PM | Modern Detection And Management Of DVT: Clinical Parameters, D-dimers And Duplex In The Era Of Cost Containment |
Presenters: Michael C. Dalsing, M.D. | |
5:17 PM - 5:23 PM | Indications, Techniques And Results With Treatment Of Venous Malformations: How Well Does Embolo/Sclerotherapy Work? |
Presenters: Byung-Boong Lee, M.D. | |
5:24 PM - 5:30 PM | What’s New In the Medical Treatment Of Thromboembolism: How To Combat The Role Of Inflammation |
Presenters: Thomas W. Wakefield, M.D. | |
5:31 PM - 5:37 PM | Is There Anything New On The Horizon With IVC Filters? |
Presenters: David Rosenthal, M.D. | |
5:38 PM - 5:44 PM | Debunking Some Commonly Held Beliefs About Varicose Veins: Some Shocking Myths And Misconceptions About Varicose Veins And Their Treatment |
Presenters: Kevin G. Burnand, M.B.B.S., F.R.C.S., M.S. | |
5:45 PM - 5:51 PM | What Is The Best Method For Obliterating Perforators In 2007: SEPS, Surgery, Duplex-Guided Sclerotherapy Or Duplex-Guided Radiofrequency: When Should They Be Used? |
Presenters: Peter Gloviczki, M.D. | |
5:52 PM - 5:58 PM | Thromboprophylaxis For Arterial And Venous Surgery: What To Use, How To Decide |
Presenters: Joseph A. Caprini, M.D. | |
5:59 PM - 6:05 PM | Chemical Ablation Of Varicose Veins Under Controlled Ischemia: Advantages, Techniques And Results |
Presenters: J. Leonel Villavicencio, M.D. | |
6:06 PM - 6:12 PM | How To Perform Sclerotherapy And Radiofrequency Effectively In An Office Practice |
Presenters: Alan M. Dietzek, M.D., F.A.C.S., R.P.V.I. | |
6:13 PM - 6:20 PM | Is There Any Association Between Obesity And Chronic Venous Disease Of The Legs? |
Presenters: Bo G. Eklof, M.D., Ph.D. | |
6:20 PM - 6:27 PM | With Varicose Veins We Really Don’t Need To Obliterate The Long Saphenous Vein! |
Presenters: John J. Bergan, M.D. | |
6:27 PM - 6:40 PM | Panel Discussion |
END OF SESSION XXVI |